Patrick Fabbio's Net Worth
$591 Thousand
Who is Patrick Fabbio?
Patrick Fabbio does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Rafael Holdings, Inc., PROGENICS PHARMACEUTICALS INC, and Protara Therapeutics, Inc..
SEC CIK
Patrick Fabbio's CIK is 0001658859
Past Insider Trading and Trends
2024 was Patrick Fabbio's most active year for acquiring shares with 2 total transactions. Patrick Fabbio's most active month to acquire stocks was the month of February. 2022 was Patrick Fabbio's most active year for disposing of shares, totalling 1 transactions. Patrick Fabbio's most active month to dispose stocks was the month of November. 2015 saw Patrick Fabbio paying a total of $846,250.00 for 125,000 shares, this is the most they've acquired in one year. In 2022 Patrick Fabbio cashed out on 27,928 shares for a total of $49,153.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Rafael Holdings, Inc. (RFL) Snapshot price: $1.49
CFO & President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.69% | -27.93K |
$1.76 | -$49,153.28 | 335.18K |
Dec 21
| |||
Form 4
|
∞
| 363.1K |
—
|
—
| 363.1K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PROGENICS PHARMACEUTICALS INC No price found
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Protara Therapeutics, Inc. (TARA) Snapshot price: $1.9505
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 22K |
—
|
—
| 22K |
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |